HOW CAN WE HELP YOU? Call 1-800-TRY-CHOP
Our team at the Congenital Hyperinsulinism Center at CHOP is working on a clinical drug trial that involves giving you a study drug called UX033.
The Dova study is for children below 18 years with primary Immune Thrombocytopenia (ITP) who have had an insufficient response to previous treatment.
The Center for Human Phenomic Science provides the resources, environment, operations, and training to support and promote high-quality clinical and translational research by qualified investigators.